Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

356
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
356
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

325
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
325
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

851
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
851
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

567
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
567

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying post-treatment vascular remodeling in brain aneurysms using WEKA-based machine learning: a pilot study.

Frontiers in neurology·2025
Same author

In Reply: The Low-Income and Middle-Income Countries' Perspective on Global Neurosurgery Collaborations.

Neurosurgery·2025
Same author

Quantitative DSA Analysis of MCA Aneurysms Using SymDIRECT Pixel Clustering: A Novel Framework for Objective Post-Treatment Evaluation.

Diagnostics (Basel, Switzerland)·2025
Same author

PATIENT-REPORTED SURVEY TO ASSESS CLINICAL STATUS AND SURGICAL OUTCOME AFTER ANTERIOR CERVICAL DISCECTOMY AND FUSION USING AN ALLOGRAFT WITH A FIXED ANGLE OF INCLINATION.

Acta clinica Croatica·2025
Same author

GIGANTISM AND ACROMEGALY THROUGH HISTORY.

Acta clinica Croatica·2025
Same author

FACTORS AFFECTING THE NON-OCCURRENCE OF ORGASM IN SLOVENIAN WOMEN.

Acta clinica Croatica·2025

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.3K

Recommendations for diabetic polyneuropathy treatment.

Vanja Basić-Kes1, Iris Zavoreo, Kresimir Rotim

  • 1University Department of Neurology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia. vanjakes@net.hr

Acta Clinica Croatica
|January 24, 2012
PubMed
Summary

Diabetic polyneuropathy, a common complication of diabetes, causes nerve damage even in prediabetes. Treatment focuses on managing blood sugar and relieving pain to improve quality of life.

More Related Videos

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.2K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.0K

Related Experiment Videos

Last Updated: Jan 11, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.3K
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.2K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.0K

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a chronic condition necessitating ongoing medical care and patient education to prevent acute and long-term complications.
  • Diabetic polyneuropathy is the most frequent complication of diabetes, representing the leading cause of morbidity and mortality in affected individuals.
  • Nerve damage may be present at the time of diabetes diagnosis, indicating a link between impaired glucose metabolism (prediabetes) and neuropathy.

Purpose of the Study:

  • To review the diagnosis and treatment of diabetic polyneuropathy.
  • To emphasize the importance of considering other causes of neuropathy when clinical presentation is atypical.
  • To outline the goals of pharmacotherapy for painful diabetic polyneuropathy.

Main Methods:

  • Diagnosis relies on clinical manifestations, laboratory findings (altered glucose metabolism), and electrophysiological examinations.
  • Treatment involves a dual approach: modifying the underlying disease (diabetes) and managing pain symptoms.
  • Pharmacotherapy aims to reduce pain, minimize side effects, and improve functional measures and quality of life.

Main Results:

  • Diabetic polyneuropathy is a common, progressive complication of diabetes, often presenting as symmetric sensory neuropathy in the lower extremities.
  • Early glucose metabolism impairment (prediabetes) is associated with neuropathy in 10%-18% of diagnosed diabetes cases.
  • Effective management requires a comprehensive approach addressing both glycemic control and symptomatic pain relief.

Conclusions:

  • Diabetic polyneuropathy is a significant complication requiring careful diagnosis and management.
  • A two-pronged treatment strategy, including disease modification and pain control, is essential for improving patient outcomes.
  • The ultimate goals of treatment are pain reduction, functional improvement, and enhanced quality of life for individuals with diabetic polyneuropathy.